Monosacáridos

N-2,4-Dinitrophenyl-deoxynojirimycin (DNPDNJ) is a methylated derivative of deoxynojirimycin. It is an inhibitor of glycosylation that can be used to study the structure and function of carbohydrates. DNPDNJ is a synthetic saccharide that can be custom synthesized. Click modification and modification with Oligosaccharides are common modifications for DNPDNJ. DNPDNJ is available in high purity and has been fluorinated for use in fluorescence studies.

6-Deoxy-2,3:4,5-di-O-isopropylidene-L-glucose is a methylated sugar that is custom synthesized for research purposes. It is an oligosaccharide with a polysaccharide backbone. 6DG has been modified with fluorination and the Click reaction to produce novel compounds. The compound has been shown to have various biological activities, including anti-inflammatory effects. 6DG is a sugar with a complex carbohydrate structure that can be used in synthetic chemistry for modification and modification reactions.

Monogalactosyldiacylglycerol (MGDG) is a polyunsaturated fatty acid, specifically a galactolipid. MGDG is synthesized by plants and plays an important role in plant physiology. MGDG is involved in the regulation of transcription and translation and also has anti-cancer properties. It has been shown that MGDG can inhibit the proliferation of breast cancer cells such as MDA-MB-231 cells through its interactions with miR-205, a microRNA that regulates cellular growth, differentiation, and apoptosis. The biochemical properties of MGDG are similar to those of diacylglycerol (DAG), which is also involved in transcriptional regulation. It has also been shown that MGDG inhibits the growth of MDA-MB-231 cells when exposed to high salt concentrations.

Please enquire for more information about N-Acetyl-D-glucosamine - plant source including the price, delivery time and more detailed product information at the technical inquiry form on this page

Competitive inhibitor of glucosylceramidase (GlcCer), which catalyses the first step in glycosphingolipid (GSL) synthesis. This compound is a promising candidate for substrate reduction therapy in Sandhoff disease, where it decreases the rate of GSL biosynthesis and counterbalances the impaired rate of ganglioside catabolism.

(1R) -1- [(2S, 3R) - 3- Hydroxy- 1- butyl - 2- azetidinyl] -1, 2- ethanediol is a glycosylase that catalyzes the hydrolysis of terminal sialic acid residues from oligosaccharides and monosaccharides. It is used in the synthesis of complex carbohydrates. This glycosylase has been shown to be highly specific for terminal sialic acids and can also be used to produce oligosaccharides with desired linkages between the sugars. The enzyme is most active at low pH and high temperatures.

6-O-Acetylglycitin is a bioactive compound that has been shown to have many physiological activities. It is the acetylated form of glycitin, which is a precursor in the synthesis of glycogen in the liver. 6-O-Acetylglycitin has been shown to promote the repair mechanism of hepatic steatosis and exhibits anti-cancer effects by inhibiting poly(ADP-ribose) polymerase chain reaction (PCR) and uvb-induced polymerase chain reaction (PCR). This compound also inhibits growth of cancer cells in vitro. 6-O-Acetylglycitin has been shown to have an analog with pharmaceutical preparations.

(-)-isolariciresinol-2a-O-b-D-xylopyranoside is a methylated saccharide that is used in the synthesis of complex carbohydrates. It is synthesized by reacting an aldehyde with an alcohol, and it has been modified using click chemistry. The product is purified to be at least 98% pure, and it can be custom synthesized to order. (-)-isolariciresinol-2a-O-b-D-xylopyranoside can be fluorinated for use as a fluorescent probe for various applications. It has a CAS number of 564964-92-1.

5-Azepan-1-yl-5-deoxy-1,2-isopropylidene-a-(D)-xylofuranose (ADXF) is a synthetic glycoside that was synthesized in order to explore the potential of ADXF as a drug candidate. ADXF has shown promising antiinflammatory and anticancer activities. The synthesis of ADXF starts with the protection of the hydroxyl group at the anomeric center with acetate and then the glycosylation with azepane and 5-deoxy-1,2 isopropylidene erythronolide B. This synthesis also includes fluorination and methylation steps, which are necessary for modifying the sugar structure.

D-Glucuronic acid (GlcA) is D-glucose with position six oxidised to a carboxyl group (Collins, 2006). It is a common component of a number of gums and mucilages structurally related to pectins, where it is can be present as a terminal non reducing end residue (Renard, 1999). Glucuronic acid is also found in bacterial polysaccharides, such as, xanthan gum produced by Xanthomonas campestris (Faria, 2011), and in glycosaminoglycans, such as, heparan sulfate (Casale, 2020).

Used as source of carbon in culture medium.

D-Arabinose is a dinucleotide phosphate that is an important metabolic intermediate in the pentose phosphate pathway. It has been shown to have pharmacological effects, such as enzyme inhibition and binding to DNA. D-Arabinose has been used in biochemical studies of energy metabolism and related areas. D-Arabinose is converted to ribitol by ribitol dehydrogenase, which can be oxidized to ribulose 5-phosphate by ribulose 5-phosphate dehydrogenase. The conversion of D-arabinose to ribitol requires NAD(P)H, which provides the reducing power for this reaction. The conversion of ribitol to ribulose 5-phosphate also requires NAD(P)H, but does not produce any reducing power. A redox potential measurement was used to determine the relative reduction potentials of the two reactions and found that they are equal at -0.5 volts (V).

Octahydro-1,2,9-tris-acetoxy-(1S,2R,9S,9aS)-quinolizin-6-one is an oligosaccharide that is a sugar modified with fluorine. It is a synthetic carbohydrate and has the CAS number 57714-00-3. The molecular weight of this compound is 784.61 g/mol. This compound can be custom synthesized to meet your needs and specifications. It has been methylated and glycosylated and has undergone click chemistry modifications.